BHF Kleinwort Benson Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-1,703,032
Closed -$52.2M 426
2015
Q4
$52.2M Buy
+1,703,032
New +$53.6M 1.2% 18
2015
Q3
Sell
-1,731,329
Closed -$55.1M 477
2015
Q2
$55.1M Buy
1,731,329
+631,510
+57% +$20.6M 1.86% 4
2015
Q1
$36.3M Sell
1,099,819
-40,070
-4% -$1.27M 1% 28
2014
Q4
$33.7M Buy
1,139,889
+128,186
+13% +$3.68M 0.87% 39
2014
Q3
$28.4M Buy
1,011,703
+42,842
+4% +$1.2M 0.93% 33
2014
Q2
$27.3M Sell
968,861
-398,465
-29% -$11.4M 0.81% 38
2014
Q1
$41.7M Buy
1,367,326
+1,018,864
+292% +$30.4M 1.2% 15
2013
Q4
$10.1M Buy
348,462
+88,888
+34% +$2.59M 0.65% 45
2013
Q3
$7.08M Buy
259,574
+9,709
+4% +$264K 0.96% 31
2013
Q2
$6.64M Buy
+249,865
New +$6.9M 0.83% 35

Other funds holding PFE

BHF Kleinwort Benson Group's PFE Position: Q1 2016 in Review

BHF Kleinwort Benson Group sold out of Pfizer (PFE) in Q1 2016, closing a stake of 1,703,032 shares — an estimated $52.2M sold.

BHF Kleinwort Benson Group first reported a position in PFE in Q2 2013 and held it in 10 quarters. The position peaked at $55.1M in Q2 2015. 1,968 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

  • BHF Kleinwort Benson Group reported no remaining Pfizer position as of Q1 2016 after selling out during the quarter.
  • BHF Kleinwort Benson Group sold 1,703,032 Pfizer shares in Q1 2016, an estimated $52.2M.
  • BHF Kleinwort Benson Group first reported a position in Pfizer in Q2 2013 and held it in 10 quarters.
  • BHF Kleinwort Benson Group's Pfizer position peaked at $55.1M in Q2 2015.
  • 1,968 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on BHF Kleinwort Benson Group's 13F filing for Q1 2016, filed 9 May 2016.